GP
Therapeutic Areas
Virax Biolabs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ViraxImmune™ IVD Platform | Post-Acute Infection Syndrome (PAIS) / General Immune Profiling | Development |
| ViraxImmune™ Assay for ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | Development |
| FluoroSpot T Cell Diagnostics Portfolio | Chronic Inflammation & T Cell Exhaustion | Pre-clinical/Development |
| Vaccine Efficacy Testing | Vaccine Development (Service) | Commercial |
| ViraxImmune™ Research Products | Immunology Research (RUO) | Commercial |
Leadership Team at Virax Biolabs
JF
James Foster
Chief Executive Officer
DN
Dr. Nigel McCracken
Chief Operating Officer
DC
Dr. Clement Monteil
Head of R&D
DI
Dr. Iain Miller
Independent Director
EN
Evan Norton
Independent Director
NH
Nelson Haight
Independent Director
DA
Dr. Ailsa Snaith
Advisory Board Member
AG
Assi Gol
Advisory Board Member
MF
Marc Frouin
Advisory Board Member
NP
Nikolas Perrault
Advisory Board Member